Condition
Relapsed and/or Refractory Multiple Myeloma clinical trials and research
As of November 12, 2026, Find a Trial lists 2 Relapsed and/or Refractory Multiple Myeloma clinical trials that are recruiting, at sites in 5 countries (most in China (1), France (1), Germany (1)). By phase: Phase 1/2 (1), Phase 1 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 2Clinical trials
- 5Countries
All recruiting trials (2)
-
CAR T-cell therapy for treating relapsed multiple myeloma
This study is testing a new type of immune therapy called OriCAR-017 to see if it can help people with relapsed multiple myeloma feel better and improve their treatment outcomes.
-
Assessing BMS-986453 for treating relapsed multiple myeloma
This study is testing a new treatment called BMS-986453, combined with other medications, to see if it can help people with relapsed multiple myeloma who haven't responded to previous therapies.
Related topics
Quick answers
How many Relapsed and/or Refractory Multiple Myeloma clinical trials are recruiting right now?
2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 5 countries. The most sites are in China (1 trial), France (1 trial), Germany (1 trial), Spain (1 trial), United States (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 1/2: 1, Phase 1: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.